Les résultats financiers d'Emerald Health Therapeutics au deuxième trimestre 2019 indiquent un doublement des ventes pour le deuxième trimestre consécutif
30 août 2019 05h10 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 30 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a communiqué aujourd'hui ses résultats financiers...
Emerald Health Therapeutics Reports Second Quarter 2019 Financial Results; Sales Double Second Quarter in a Row
29 août 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended June 30,...
La coentreprise Pure Sunfarms d'Emerald Health Therapeutics a réalisé un chiffre d'affaires de 32 millions $ au deuxième trimestre, une marge d'EBITDA de 78 %, un coût de production global de 0,65 $/g et un troisième trimestre de rentabilité consécutif
13 août 2019 11h32 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, Colombie-Britannique, 13 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH, OTCQX: EMHTF) a publié des résultats financiers préliminaires non...
Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
13 août 2019 00h19 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has provided preliminary, unaudited financial results for the...
Emerald Health Therapeutics Appoints Chief Executive Officer
30 juil. 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
Riaz Bandali has driven innovation, sales, and profitability in a number of global life science companies Emerald also adds Chief Commercial Officer VICTORIA, British Columbia, July 30, 2019 ...
CapStar Reports Fully Diluted EPS of $0.25 and Fully Diluted Operating EPS of $0.28 for 1Q2019
24 avr. 2019 16h20 HE
|
CapStar Financial Holdings, Inc.
NASHVILLE, Tenn., April 24, 2019 (GLOBE NEWSWIRE) -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported net income of $4.78 million, or $0.25 per share on a fully diluted basis, for...
Traditional cost-cutting measures aren’t enough to solve current profitability crisis in Financial Services industry
05 févr. 2019 09h58 HE
|
PwC
NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- In a new report titled: The productivity agenda – moving beyond cost reduction in financial services, PwC sets out the important challenges and...
CapStar Reports Fully Diluted EPS of ($0.04) and Fully Diluted Operating EPS of $0.33 for 4Q 2018
24 janv. 2019 19h09 HE
|
CapStar Financial Holdings, Inc.
NASHVILLE, Tenn., Jan. 24, 2019 (GLOBE NEWSWIRE) -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported a net loss of ($0.7) million, or ($0.04) per share on a fully diluted basis,...
Asset Managers’ Global Growth Surge Sets Stage for Digital Competition
19 juil. 2018 12h00 HE
|
BCG
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- A surge in global growth by the asset management industry, occurring as advanced digital and analytics are finally going mainstream, has positioned firms...
First Horizon Declares Quarterly Dividends
24 avr. 2018 16h15 HE
|
First Horizon National Corporation
MEMPHIS, Tenn., April 24, 2018 (GLOBE NEWSWIRE) -- First Horizon National Corp.'s (NYSE:FHN) board of directors has approved payment of a quarterly cash dividend on its common stock of $.12 per...